A randomized, open label study to evaluate the effect of oral and intravenous Bondronat [ibandronic acid] on pain response in elderly patients with bone metastases from different tumor types.
Phase of Trial: Phase II
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Ibandronic acid; Ibandronic acid
- Indications Breast cancer; Cancer metastases; Lung cancer; Prostate cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Roche
- 18 Apr 2009 Status changed from completed to discontinued as reported by Roche.
- 24 Apr 2007 New trial record.